Use of the Brattleboro rat in studies of the mechanism by which chlorpropamide enhances the action of vasopressin.
D000262:Adenylyl Cyclases / Q000378:metabolism; D000818:Animals; D001127:Arginine Vasopressin / Q000494:pharmacology*; D002747:Chlorpropamide / Q000494:pharmacology*; D000242:Cyclic AMP / Q000378:metabolism; D003894:Deamino Arginine Vasopressin / Q000494:pharmacology*; D003919:Diabetes Insipidus / Q000378:metabolism; D015232:Dinoprostone; D004231:Diuresis / Q000187:drug effects; D004347:Drug Interactions; D004789:Enzyme Activation / Q000187:drug effects; D007679:Kidney Medulla / Q000187:drug effects / Q000378:metabolism; D011458:Prostaglandins E / Q000652:urine; D051381:Rats; D011910:Rats, Brattleboro / Q000378:metabolism*; D011922:Rats, Mutant Strains / Q000378:metabolism*
D011458:Prostaglandins E; D001127:Arginine Vasopressin; D000242:Cyclic AMP; D000262:Adenylyl Cyclases; D003894:Deamino Arginine Vasopressin; D015232:Dinoprostone; D002747:Chlorpropamide